Flying on two Wings: Ypsomed’s Dual-Engine Strategy for Success in China
Hong Cui, Orfeo Niedermann and Shawn James of Ypsomed discuss how their company has succeeded in China, highlighting the importance …
White Papers
-
-
Interview: Enhancing Clinical Trials with CliniPilot® and Clear to Clinic™ Programme
Today, pharma companies are aiming to accelerate clinical development for faster time to market without compromising on data quality or …
-
Beyond Drug Delivery: Three Lenses for Selecting an On-Body Platform
Reto Jost, Nadine Kaufmann and Shawn James, all of Ypsomed, discuss three complementary decision lenses and explain how they offer …
-
Bio-Based Plastics in Drug Delivery: From Material Equivalence to Systemic Decarbonisation
Nadine Kaufmann and Michael Schori of Ypsomed analyse the feasibility of introducing sustainable materials within current regulatory frameworks, demonstrating this …
-
GxP Compliance for SaaS Applications: A Practical Guide for Pharmaceutical, Biotech and Medical Device Organisations
Pharmaceutical, biotechnology and medical device companies face a recurring challenge: determining whether a Software as a Service (SaaS) platform is …
-
Sterile Filtration of Budesonide as a Preferred Sterilisation Strategy
Sterile budesonide manufacturing requires a sterilisation strategy that protects both chemical integrity and critical quality attributes. Because the molecule is …
-
Continuous Manufacturing: A Novel and Enabling Tool to Overcome API Batch Manufacturing Limitations
While batch processing remains the dominant manufacturing approach for pharmaceutical APIs, continuous manufacturing is increasingly being adopted to address challenges …
-
Next-Generation CAR-T Design: Overcoming TME Barriers with Armoured Payloads and Logic-Gated Precision
Solid tumours are not “harder blood cancers.” They are engineered ecosystems—mechanically fortified, metabolically hostile, and immunologically suppressive. Next-gen CAR-T success …
-
From Autologous to Universal: Efficiency Strategies to Accelerate Next-Generation Immune Cell Therapy (CAR-NK/iPSC) R&D
Cell therapy is entering a phase where operational efficiency is becoming as decisive as scientific novelty. Autologous CAR-T has demonstrated …
-
Fermentation Development And Manufacturing
Curia designs and scales microbial fermentation and biocatalytic processes, coupled with advanced chemical synthesis to deliver safer, greener and more …
-
FAQ: Fermentation & Biocatalysis in Modern Manufacturing
Microbial fermentation is a metabolic process that uses microorganisms, such as bacteria, yeast, or fungi, to convert raw materials (carbon …
-
Industrial Chromatography: A Guide to Scale-Up and Purification for Small and Large Molecules
At its core, chromatography is a physical method of separation in which the components of a mixture are distributed between two …
-
From Lipid Screening to Commercialisation
From grams to GMP multi‑ton scale, Curia integrates lipid chemistry and purification to deliver faster timelines and higher yields.
-
When Is Preparative Chromatography Actually Necessary?
Preparative chromatography is not automatically the next step after synthesis or extraction. It is one of several purification options alongside …
-
Why Pressure Becomes a Scale-Up Problem in Preparative Chromatography
A C18 method may deliver excellent separation on an analytical HPLC—and still become impractical when production volume increases. The difficulty is …